Breast Cancer Action Quebec (formerly Breast Cancer Action Montreal) advocates for breast cancer prevention and the elimination of environmental toxins linked to the disease. We work to empower people to make the societal changes needed to stop the disease before it starts.



FemmeToxic's goal is to educate young Canadian women about the potential dangers of cosmetics ingredients and provide people with the tools they need to create personal change and to influence national legislative reform. Refuse to be “toxified”! Demand safer cosmetics!

Prevention and Action against Cancer and Toxicants
The PACT project is an education and mobilization project for Quebec community groups with the goals of sensitizing them to the dangers of toxicants in consumer products.


3I: Influence, Initiative, Impact is created to address the leadership component of FemmeToxic by working with five young women's community groups in and around Montreal. 3I will help promote young women's leadership in community, civic and political actions. This is an exciting opportunity for us to work with young leaders!

Hands off my Hormones! Take a Stand against Endocrine Disruptors: Campaign launched to inform people of the disastrous, multiple effects of endocrine disrupting chemicals (EDCs) on human health. Studies have shown them to be linked to breast cancer, prostate cancer and other chronic illnesses. They are ubiquitous; found in cosmetics, cleaners, canned foods and cars.

What's happening

News Briefs March 2014

Chemotherapy prolongs survival in isolated loco-regional recurrence of breast cancer. A recurrence of breast cancer in the chest wall or regional lymph nodes, without evidence of metastasis, is designated as “isolated loco-regional recurrence (ILRR)” and occursin from 5% to 40% of women within ten yearsfollowing a mastectomy with no radiation.  Recent studies have looked at chemotherapy for ILRR; this study found that chemotherapy made a significant difference for women originally diagnosed with estrogen receptor negative (ER-) cancers.  However, the authors suggest that women originally diagnosed with estrogen receptor positive (ER+) cancers may also benefit.(Aebi S, Gelber S, Anderson SJ et al.  Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): A randomised trial.The Lancet Oncology;15,2:156-163)

Rapid testingfor BRCA informs choice of mastectomy. Italian researchers studied a rapid genetic counseling and testing intervention offered to women recently diagnosed with breast cancer and at risk of BRCA-1 or BRCA-2 mutations. Whereas routine referral often took six months, this observational study used a 3- to 4-week turn-around. Moreover, routine referral takes place after surgery, whereas this trial provided information prior to surgery.  Of over one thousand women treated at the clinic in the usual way, about one in five was found to be mutation carriers; of these, one in 20 chose to have a second mastectomy.  When rapid intervention was implemented, one-third of slightly more than 100 women tested positive for a mutation and 40% of these chose a double mastectomy. Patients’ decisions were based not only on possible prolongation of their own lives but also by feelings of responsibility to their children. (Cortesi L, Razzboni E, Toss A et al. A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA-1 or -2 positive Italian women. Ann Oncol.2014;25:57-63)

May 20 2014 - 1:16pm